Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Salarius Pharmaceuticals: Q2 Earnings Insights

Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q2 earnings results on Friday, August 5, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q2 earnings results on Friday, August 5, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Salarius Pharmaceuticals beat estimated earnings by 10.0%, reporting an EPS of $-0.09 versus an estimate of $-0.1.

Revenue was down $571 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 15.36% drop in the share price the next day.

 

To track all earnings releases for Salarius Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

CryoPort’s Earnings: A Preview

By Benzinga Insights
August 3, 12:11 PM
CryoPort (NASDAQ:CYRX) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that CryoPort will report an earnings per share (EPS) of $-0.15.

CYRX